Earlier in March, rumors swirled that applied behavior analysis (ABA) software company CentralReach was on the market and seeking a $1 billion valuation. Those rumors have quickly turned into reality. Roper Technologies Inc. (Nasdaq: ROP) announced Monday that it has reached a definitive agreement to buy CentralReach from Insight Partners for a net purchase price […]
Category: Treatment Type
Twenty-eight million adults in the U.S. have alcohol use disorder (AUD), and the life-threatening condition particularly impacts Medicaid populations. Despite the existence of evidence-based medications for AUD, less than half of all Medicaid managed care plans cover all types of medications for AUD, according to a new study published in JAMA Network Open. “The results […]
This is an exclusive BHB+ story Venture capital investors inherently take on risk when backing a new behavioral health company. Sometimes, that risk pays off in dividends. Other times, not so much. Deciding when an investment is no longer worthwhile is a difficult decision, investors told Behavioral Health Business. Investors want to avoid losing their […]
CEO transition at Ivy Rehab Ivy Rehab has named Jason Strauss its new CEO after the acting CEO, Michael Rucker, announced his plans to retire at the end of April. Strauss has 20 years of experience in the health care industry. Most recently, he served as CEO of ambulatory care provider SCA Health. His resume […]
Digital ABA software startup Motivity has raised $27 million to expand its team and accelerate product development. The Hawaii-based startup offers a software service that can collect data, provide analysis and offer reporting capabilities to support ABA therapy. The latest cash infusion will allow the company to expand its research and develop clinical decision-support tools. […]
The Trump administration’s drastic government workforce cuts may impact the substance use disorder (SUD) industry, and lawmakers are pushing back. The Substance Abuse and Mental Health Services Administration (SAMHSA), the federal organization that regulates and funds several aspects of the behavioral health industry, has already experienced a workforce cut – and may be facing far […]
As the opioid epidemic approaches its second decade of devastating impact, some health care providers are integrating evidence-based research into their clinical practice to combat this persistent crisis. Nonprofit substance use disorder (SUD) provider Caron Treatment Centers has taken the approach of integrating research into care. Caron’s Chief Medical Officer, Adam Scioli, said having research […]
Wysa, an AI-powered mental health chatbot company, has acquired April Health, a behavioral health company that partners with primary care providers. The acquisition expands Wysa’s behavioral health offerings to include both human and AI options. It also allows the company to overcome the challenge of getting reimbursed for its services, Ramakant Vempati, co-founder and president […]
Wait times are the manifestation of several parts of the autism therapy industry being out of balance. Despite the significant expansion of access to treatment service providers, the process of going from parent concern to diagnosis to treatment is slow-moving and full of opportunities for potential delay. This results in a nuanced system fractured along […]
Fort Lauderdale, Florida-based CentralReach, a dominant player in the autism therapy software world, is reportedly eyeing a sale and retained an investment bank. Business Insider reports that the William Blair & Co. is now working with CentralReach and seeking a sale at a valuation of $1 billion on $75 million in adjusted earnings. Both a […]